Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer
Author:
Affiliation:
1. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
2. Department of Nursing, Colorectal Cancer Center, Samsung Medical Center, Seoul, Korea.
Publisher
Korean Society of Coloproctology
Link
http://coloproctol.org/upload/pdf/jksc-26-287.pdf
Reference19 articles.
1. Cancer Statistics, 2009
2. Worldwide Variations in Colorectal Cancer
3. Use of Adjuvant Chemotherapy and Radiation Therapy for Colorectal Cancer in a Population-Based Cohort
4. American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
5. Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients;Molecular Diagnosis & Therapy;2022-02-03
2. Global Cancer Burden and Natural Disasters: A Focus on Asia’s Vulnerability, Resilience Building, and Impact on Cancer Care;Journal of Global Oncology;2019-12
3. Association Between Adjuvant Chemotherapy Duration and Survival Among Patients With Stage II and III Colon Cancer;JAMA Network Open;2019-05-17
4. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE);Journal of Advanced Nursing;2015-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3